Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | AGN | MYL | TEVA | BHC |
| Company | Cymabay Therapeutics | Allergan Plc | Mylan NV Ord Shs | Teva Pharmaceutical Industries ADR | Bausch Health Companies Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NYSE |
| Open | 32.49 | 193.01 | 15.64 | 13.26 | 8.60 |
| High | 32.50 | 193.38 | 16.15 | 13.29 | 8.63 |
| Low | 32.48 | 191.64 | 15.34 | 13.06 | 8.48 |
| Last | 32.48 | 193.02 | 15.86 | 13.11 | 8.55 |
| Change | +0.01 | +0.03 | +0.31 | -0.12 | -0.08 |
| % Change | +0.03% | +0.02% | +1.96% | -0.91% | -0.93% |
| Volume | 8,356,200 | 12,442,600 | 26,574,100 | 5,034,227 | 1,005,238 |
| 20-Day Average Volume | 3,390,805 | 4,993,145 | 8,612,350 | 8,414,883 | 3,887,476 |
| Previous Close | 32.47 | 192.99 | 15.55 | 13.23 | 8.63 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | No | No | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 188.05 | 15.15 | 13.84 | 9.63 |
| 20-Day Raw Stochastic | 94.12% | 76.90% | 86.27% | 6.41% | 7.26% |
| 20-Day Relative Strength | 78.00% | 59.14% | 55.75% | 45.49% | 40.88% |
| Weighted Alpha | +247.60 | +28.20 | -23.10 | +62.89 | -1.92 |
| Today's Opinion | 100% Buy | 72% Buy | 40% Sell | 56% Buy | 56% Buy |
| Previous Opinion | 100% Buy | 56% Buy | 64% Sell | 56% Buy | 56% Buy |
| Last Month's Opinion | 100% Buy | 24% Sell | 64% Sell | 100% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | +1.73% since 05/01/20 | +4.86% since 11/09/20 | -5.87% since 04/09/24 | -7.29% since 04/09/24 |
| Low | 32.44 on 03/15/24 | 187.75 on 05/04/20 | 15.10 on 11/10/20 | 13.06 on 04/16/24 | 8.36 on 04/11/24 |
| High | 32.50 on 03/21/24 | 196.45 on 05/06/20 | 16.15 on 11/16/20 | 13.99 on 04/10/24 | 9.87 on 04/11/24 |
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | +6.59% since 04/08/20 | +0.92% since 10/16/20 | -2.08% since 03/15/24 | -6.68% since 03/15/24 |
| Low | 32.15 on 02/22/24 | 181.21 on 04/09/20 | 14.00 on 10/29/20 | 13.06 on 04/16/24 | 8.36 on 04/11/24 |
| High | 32.50 on 03/21/24 | 196.45 on 05/06/20 | 16.15 on 11/16/20 | 14.47 on 04/08/24 | 11.46 on 04/03/24 |
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | -2.05% since 02/07/20 | -2.07% since 08/14/20 | +19.55% since 01/16/24 | +2.20% since 01/16/24 |
| Low | 22.11 on 01/26/24 | 158.67 on 03/18/20 | 14.00 on 10/29/20 | 10.83 on 01/17/24 | 7.68 on 02/05/24 |
| High | 32.50 on 03/21/24 | 202.21 on 02/12/20 | 17.03 on 08/19/20 | 14.47 on 04/08/24 | 11.46 on 04/03/24 |
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | +6.48% since 11/08/19 | +4.58% since 05/15/20 | +50.46% since 10/16/23 | +16.17% since 10/16/23 |
| Low | 12.32 on 10/13/23 | 158.67 on 03/18/20 | 14.00 on 10/29/20 | 8.06 on 10/23/23 | 6.53 on 11/13/23 |
| High | 32.50 on 03/21/24 | 202.21 on 02/12/20 | 19.24 on 06/08/20 | 14.47 on 04/08/24 | 11.46 on 04/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 63,503,972 | 8,586,212 | 14,832,072 | 3,153,506 |
| Shares Outstanding, K | 114,724 | 329,002 | 541,546 | 1,121,094 | 365,412 |
| Annual Sales | 31,070,000 | 16,088,900,000 | 11,500,500,000 | 15,846,000,000 | 8,757,000,000 |
| Annual Net Income | -105,370,000 | -5,271,000,000 | 16,800,000 | -559,000,000 | -592,000,000 |
| Last Quarter Sales | 60,000 | 4,351,000,000 | 2,972,100,000 | 4,457,000,000 | 2,408,000,000 |
| Last Quarter Net Income | -41,900,000 | -317,200,000 | 185,700,000 | 429,000,000 | -39,000,000 |
| 60-Month Beta | 0.32 | 1.20 | 1.45 | 1.05 | 0.85 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | 5.22 on 02/10/20 | 0.36 on 11/06/20 | 1.00 on 01/31/24 | 1.15 on 02/22/24 |
| Latest Earnings Date | 03/21/24 | 05/07/20 | 11/06/20 | 05/08/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.740 on 04/15/20 | 0.060 on 06/27/07 | 0.072 on 11/27/17 | 1.000 on 11/10/10 |
| Next Ex-Dividends Date | N/A | 04/15/20 | N/A | 11/27/17 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 10.94 | 3.29 | 5.38 | 2.50 |